Neutralization
Showing 26 - 50 of 973
New York City Observational Study of Mpox Immunity
Recruiting
- Monkeypox
- +2 more
-
New York, New YorkNYU Langone Health
Dec 19, 2022
Hand, Foot and Mouth Disease Trial (EV71 Vaccine)
Not yet recruiting
- Hand, Foot and Mouth Disease
- EV71 Vaccine
- (no location specified)
Nov 17, 2023
Vaccine Trial in Russian Federation (Vaccine for intramuscular injection, Placebo comparator (without active ingredient) for
Active, not recruiting
- Vaccine
- Vaccine for intramuscular injection
- Placebo comparator (without active ingredient) for intramuscular injection
-
Elektrostal, Moscow, Russian Federation
- +3 more
Feb 7, 2023
Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Immune Response of
Not yet recruiting
- Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
- +6 more
- ChulaCov19 BNA159 mRNA vaccine
-
Bangkok, Thailand
- +1 more
Nov 30, 2022
COVID-19 Infection Trial in Turkey (Taking biological samples (blood) and keeping records with phone calls)
Active, not recruiting
- COVID-19 Infection
- Taking biological samples (blood) and keeping records with phone calls
-
Ankara, Turkey
- +7 more
May 16, 2023
HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)
Suspended
- HIV Infections
- BG505 MD39.3 mRNA
- +2 more
-
Birmingham, Alabama
- +9 more
Feb 1, 2023
Anthrax Trial in Yeongeon-dong (GC1109 or Placebo of GC1109)
Completed
- Anthrax
- GC1109 or Placebo of GC1109
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 2, 2023
COVID-19 Infection Trial in ¨Paris (serology test, nasopharyngeal swab, rectal swab)
Completed
- COVID-19 Infection
- serology test
- +3 more
-
¨Paris, FranceHôpital necker Enfants-Malades
Feb 1, 2023
Immunogenicity, Efficacy, Safety Trial in Savannakhét (SW-BIC-213, SARS-Cov-2 Vaccina(Vero Cell ) Inactivated)
Recruiting
- Immunogenicity
- +2 more
- SW-BIC-213
- SARS-Cov-2 Vaccina(Vero Cell ) Inactivated
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Oct 11, 2022
Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single
Not yet recruiting
- Safety of a Single Dose of COMVIGEN Vaccine
- +5 more
- Comvigen (Bivalent, ChulaCov19 BNA159.2)
- BIVALENT Pfizer/BNT vaccine
-
Bangkok, Thailand
- +1 more
Jun 29, 2023
COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO
Active, not recruiting
- COVID-19
- low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
- +2 more
-
Shang Qiu, He Nan, ChinaNing ling Center for Disease Control and Prevention
Jan 31, 2023
TIXAGEVIMAB/CILGAVIMAB Protection of Covid-19 in Transplanted
Withdrawn
- Solid Organ Transplant Recipients
- Blood and saliva samplings
-
Lyon, France
- +1 more
Aug 29, 2022
Metropolitan Area of Buenos Aires
Not yet recruiting
- Dengue
- Flavivirus Infections
- Dengue Immunoglobulin G antibodies performed with ELISA
- (no location specified)
Jun 21, 2023
Anthrax Trial in United States (AV7909 Full Dose (0.5 mL), AV7909 Half Dose (0.25 mL))
Not yet recruiting
- Anthrax
- AV7909 Full Dose (0.5 mL)
- AV7909 Half Dose (0.25 mL)
-
Hickory, North Carolina
- +6 more
Aug 10, 2023
SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)
Recruiting
- SARS-CoV-2 Infection
- Full dose of Ad26.COV2. 5x10^10vp
- Half dose of Ad26.COV2. 2.5x10^10vp
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022
COVID-19 Trial in Tehran (Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SARS-CoV-2 recombinant spike
Completed
- COVID-19
- Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
-
Tehran, Iran, Islamic Republic ofOrchid Life Department, Orchid Pharmed Company
Oct 13, 2022
Covid19 Trial in Hong Kong (Tozinameran, CoronaVac, CoronaVac, intradermal)
Active, not recruiting
- Covid19
- Tozinameran
- +2 more
-
Hong Kong, Hong Kong, ChinaQueen Mary Hospital
Jul 14, 2022
Covid19 Trial in Falun, Stockholm (SARS-CoV-2 convalescent plasma, Standard of care)
Completed
- Covid19
- SARS-CoV-2 convalescent plasma
- Standard of care
-
Falun, Dalarn, Sweden
- +2 more
Jan 26, 2022
Tick Borne Encephalitis Trial in Vienna (TBE virus vaccine)
Completed
- Tick Borne Encephalitis
- TBE virus vaccine
-
Vienna, AustriaMedical University of Vienna, Department of Medicine I, Division
Jan 27, 2022
COVID-19 Trial in Wong Chuk Hang (COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain)
Recruiting
- COVID-19
- COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
-
Wong Chuk Hang, HongKong, ChinaGleneagles Hospital HongKong
Jul 4, 2022
Prevention of Dengue Fever Trial in Adelaide (Dengusiil, Placebo)
Completed
- Prevention of Dengue Fever
- Dengusiil
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Aug 16, 2022
Assess Immunogenicity of Nationally Authorized Homologous
Not yet recruiting
- COVID-19
- Immune Responses
- (no location specified)
Jan 31, 2023
COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)
Active, not recruiting
- COVID-19
- SARS-CoV-2 protein subunit recombinant vaccine
- SARS-CoV-2 inactivated vaccine
-
Semarang, Central Java, Indonesia
- +1 more
Aug 8, 2022
Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)
Not yet recruiting
- Sudan Ebola Virus Vaccines
- CAd3
- +3 more
- (no location specified)
Jun 8, 2023